Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
SkyePharma
SkyePharma
Activities:
Manufacturing
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Drug Delivery
SkyePharma signs exclusive licensing agreement to access Lucideon’s abuse deterrent drug delivery technology
First product to be developed for the growing $11bn US opioid market
Manufacturing
Skyepharma installs MG2 Planeta
To address its needs for the production of pilot and clinical batches of inhalation products and third party projects
Research & Development
David Lescuyer joins SkyePharma as Executive Vice President, Oral Business
He will be responsible for Skyepharma’s Oral Business including, after 30 June, the manufacturing operations in Saint-Quentin Fallavier, France
Finance
Vectura and Skyepharma agree to merge
Respiratory drug delivery specialists will become an industry-leading airways-related speciality business
Research & Development
Skyepharma acquires novel inhaled therapy platform
New product opportunity to be developed as an anti-inflammatory treatment for COPD
Drug Delivery
Flutiform sales drive growth at SkyePharma
Plans to raise £112m in capital to pay off bond debt and strengthen product pipeline
Drug Delivery
SkyePharma reports strong revenue growth
Underpinned by sales of Flutiform and use of proprietary dry powder formulation technology in GSK product
Subscribe now